HO-1 inhibits the activation of the TGF-ß/Smad3 pathway in NAFLD-related liver fibrosis through SIRT1. These findings provide insights into new therapeutic strategies for treating NAFLD-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback